Speakers: Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S. Food and Drug Administration (FDA) Adrian F. Hernandez, MD, MHS Vice Dean and Executive Director Duke Clinical Research Institute Duke University […]